Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v5-FR
Language English French
Date Updated 2020-05-13 2020-03-04
Drug Identification Number 01959034 01959034
Brand name ACT-HIB ACT-HIB
Common or Proper name Haemophilus b Conjugate Vaccine (Tetanus Protein – Conjugate) Haemophilus b Conjugate Vaccine (Tetanus Protein – Conjugate)
Company Name SANOFI PASTEUR LIMITED SANOFI PASTEUR LIMITED
Ingredients TETANUS PROTEIN HAEMOPHILUS INFLUENZAE TYPE B-PRP TETANUS PROTEIN HAEMOPHILUS INFLUENZAE TYPE B-PRP
Strength(s) 30MCG 10MCG 30MCG 10MCG
Dosage form(s) KIT POWDER FOR SOLUTION KIT POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 5 x 0.5 mL vials 5 x 0.5 mL vials
ATC code J07AG J07AG
ATC description BACTERIAL VACCINES BACTERIAL VACCINES
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2020-03-03 2020-03-03
Actual start date 2020-03-03 2020-03-03
Estimated end date 2020-06-15 2020-06-15
Actual end date 2020-05-12
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Shortage due to delays in manufacturing and shipment of product for Canada. Allocation plan in place to meet public market demand. Product not available for private market. Resolved on Wednesday May 13, 2020. Shortage due to delays in manufacturing and shipment of product for Canada. Allocation plan in place to meet public market demand. Product not available for private market.
Health Canada comments